| Scorecard |
|---|
|
5 / 5 Stars
|
|
Lipper
5
5
4
3
3
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
B
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 0.34 | 0.34 |
| Stocks | 90.72 | 90.72 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 8.95 | 8.95 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| International Business Machines Corp | IBM | 4.66 | 4.93 |
| Biogen Idec Inc | BIIB | 46.43 | 4.46 |
| Salesforce.com, Inc. | CRM | -1.11 | 4.13 |
| Amgen Inc | AMGN | 21.82 | 2.37 |
| Lockheed Martin Corporation | LMT | 8.9 | 2.23 |
| F5 Networks, Inc. | FFIV | -23.71 | 2.06 |
| Sap AG ADR | SAP | -1.88 | 1.86 |
| VMware, Inc. | VMW | -25.16 | 1.82 |
| Thermo Fisher Scientific Inc | TMO | 26.8 | 1.77 |
| Valeant Pharmaceuticals International Inc | VRX | 23.29 | 1.73 |
